News

Found 7 Results

KBio Announces Supply Agreement for Plant-Derived Recombinant Aprotinin

October 21, 2024

LONDON, October 21, 2024 – KBio, one of the leading developers of new biological treatments derived from a plant-based production […]

KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid Myelitis and the First Patient Dosed in the Phase 1 Study

June 28, 2024

LONDON, June 28, 2024 – KBio, one of the leading developers of new biological treatments derived from a plant-based production […]

KBio and ZERO Announce Exclusive Strategic Alliance to Develop a Globally Distributed and Rapidly Deployable Plant-Based Molecular Farming Network

August 1, 2023

WORLD’S FIRST GLOBALLY DISTRIBUTED AND RAPIDLY DEPLOYABLE PLANT-BASED MOLECULAR FARMING NETWORK TO INCLUDE THERAPEUTIC, PANDEMIC PREPAREDNESS AND BIOACTIVE INGREDIENT PRODUCTION […]

KBio Announces Strategic Collaboration with Leaf Expression Systems to Enhance Development and Production of Novel Therapeutics

September 28, 2022

LONDON — September 28, 2022— KBio, a leading developer of new biological treatments derived from a plant-based production system, today […]

KBio Announces Strategic Partnership with ZabBio to Discover and Develop Antibody Therapeutics

September 13, 2022

LONDON and SAN DIEGO— September 12, 2022—KBio, a leading developer of new biological treatments derived from a plant-based production system, […]

KBio Appoints Sean Stevens, Ph.D. as Chief Scientific Officer

May 5, 2022

LONDON, May 05, 2022 — KBio, a leading developer of new biological treatments derived from a plant-based production system, today […]

BAT creates biotech company KBio to accelerate development of existing plant-based technology

January 7, 2022

BAT today announced the launch of KBio Holdings Limited (KBio) to accelerate the research, development and production of novel treatments. […]

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
CookieLawInfoConsent	1 year	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
elementor	never	The website's WordPress theme uses this cookie. It allows the website owner to implement or change the website's content in real-time.
PHPSESSID	session	This cookie is native to PHP applications. The cookie stores and identifies a user's unique session ID to manage user sessions on the website. The cookie is a session cookie and will be deleted when all the browser windows are closed.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_pk_id.####	1 year 1 month	Used to store a few details about the user such as the unique visitor ID.
_pk_ses.####	1 hour	Short lived cookies used to temporarily store data for the visit.